LOCALIZATION OF THE PHYSIOLOGICAL PRION AND Na+–K+ ATPase ACTIVITY IN TISSUES OF RATS PRION-REPLICATING SYSTEM

M. V. Kushkevych, V. V. Vlizlo, Y. V. Martyn


DOI: http://dx.doi.org/10.30970/sbi.0503.167

Abstract


Immunohistochemical studies of prion-replicating tissues, in six months rats, showed presence of the physiological prion in small intestine, particularly in cells of the jejunum villi own plate – lymphocytes and monocytes. In spleen, physiological prion localization was found in red pulp lymphocytes, located near the capsule and tra­becules. In cells of white pulp the physiological prion was not found. Instead, most of it was located in microgluecytes of medulla oblongata. The Na+–K+ ATPase activity and the concentration of sodium and potassium ions in rat prion-replicating organs were determined. Enzyme activity was highest in the medulla oblongata, and the concentration of ions – in spleen. A direct positive correlation between the amount of physiological prion and the activity of Na+–K+ ATPase was established.


Keywords


prion-replicating organs, physiological prion, Na+–K+ АТPase, sodium and potassium ions

References


1. Болдырев А.А. Na+-K+ АТФ-аза как олигомерный ансамбль. Биохимия, 2001; 66(8): 1013-1025.

2. Вербицький П.І. Губчастоподібна енцефалопатія великої рогатої худоби та інші пріонні інфекції. К.: Ветінформ, 2005. 240 с.

3. Григорьев В.Б. Прионные болезни человека и животных. Вирусология, 2004; 49(5): 4-12.

4. Лакин Г.Ф. Биометрия. М.: Высш. школа, 1990. 352 с.

5. Лапач С.И., Губенко А.В., Бабич П.П. Статистические методы в медико-биологических исследованиях с использованием Excel. Киев: Морион, 2000. 319 с.

6. Лопина О. Д. Взаимодействие каталитической субъединицы Na/K-АТФ-азы с клеточными белками и другими эндогенными регуляторами. Биохимия, 2001; 66(10): 1389-1400.

7. Новак В.П., Мельниченко А.П. Цитологія, гістологія, ембріологія: навч. посібник. Біла Церква, 2005. 256 с.

8. Остапченко Л.І., Михайлик І.В. Біологічні мембрани: методи дослідження структури та функцій. К.: ВПЦ Київський університет, 2006. 215 с.

9. Тица Н. Энциклопедия клин. лаб. тестов. Москва: Лабинформ, 1997. С. 225-226.

10. Шкундина И.С., Тер-Аванесян М.Д. Прионы. Успехи биол. химии, 2006; 46: 3-423.

11. Alper T., Haig D.A., Clarke M.C. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun, 1966; 22(3): 278-284.
https://doi.org/10.1016/0006-291X(66)90478-5

12. Caetano F.A., Lopes M.H. Endocytosis of Prion Protein Is Required for ERK1/2 Signaling Induced by Stress-Inducible Protein 1. Journ. of Neuroscience, 2008; 28(26): 6691-6702.
https://doi.org/10.1523/JNEUROSCI.1701-08.2008
PMid:18579743 PMCid:PMC2739057

13. Jorgensen P. L. Purification of Na+-K+ АТPase: enzyme sources, preparative problems, and preparation from mammalian kidney. Methods in Еnzymology, 1988; 156: 29-43.
https://doi.org/10.1016/0076-6879(88)56005-6

14. Hope J., Reekie L., Hunter N. et al. Fibrils from brains of cows with new cattle disease contam scrapieassociated protein. Nature, 1988; 336: 390-392.
https://doi.org/10.1038/336390a0
PMid:2904126

15. Kingsbury D.T., Smeltzer D.A., Gibbs C.J., Gajdusek D.C. Evidence for normal cell-mediated immunity in scrapie-infected mice. Infect. Immun, 1981; 32: 1176-1180.

16. Kovacs G., Budka H. Prion Diseases: From Protein to Cell Pathology. Am. Journ. of Pathology, 2008; 172(3): 555-565.
https://doi.org/10.2353/ajpath.2008.070442
PMid:18245809 PMCid:PMC2258253

17. Krammer C., Vorberg I., Schatzl H.M., Gilch S. Therapy in Prion Diseases: From Molecular and Cellular Biology to Therapeutic Targets. Infections Disorders - Drug Targets, 2009; 9: 3-14.
https://doi.org/10.2174/1871526510909010003

18. Kuehnel W. Color Atlas of Cytology, Histology and Microscopic Anatomy. New York: Thieme Stuttgart, 2003. 534 p.
https://doi.org/10.1055/b-005-148882

19. Lowry O.N., Rosenbrough N.I., Forr A.R. et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem, 1951; 193(1): 265-275.

20. Linden R, Martins V.R., Prado M.A. Physiology of the Prion Protein. Physiol Rev, 2008; 88: 673-728.
https://doi.org/10.1152/physrev.00007.2007
PMid:18391177

21. Prusiner S.B. Genetic and infectious prion diseases. Arch. Neurol, 1993; 50: 1129-1153.
https://doi.org/10.1001/archneur.1993.00540110011002
PMid:8105771

22. Tessier P., Lindquist S. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nature Structural & Molecular Biology, 2009; 16(6): 598-605.
https://doi.org/10.1038/nsmb.1617
PMid:19491937 PMCid:PMC4502417

23. Westergard L., Christensen H., Harris D. The cellular prion protein (PrPC): its physiological function and role in disease. Biochim. Biophys. Acta, 2007; 1772: 629-644.
https://doi.org/10.1016/j.bbadis.2007.02.011
PMid:17451912 PMCid:PMC1986710

24. Weissmann C. The state of the prion. Nat. Rev. Microbiol, 2004; 2: 861-871.
https://doi.org/10.1038/nrmicro1025
PMid:15494743

25. Will R.G. The spongioform encephalopathies. J. Neurol. Neurosurg. Psychiat, 1991; 54: 761-763.
https://doi.org/10.1136/jnnp.54.9.761
PMid:1955893 PMCid:PMC1014511

26. Winklhofer K.F., Heske J., Heller U. et al. Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation. J. Biol. Chem, 2003; 278(17): 14961-14970.
https://doi.org/10.1074/jbc.M209942200
PMid:12556465

27. Yuan J., Xiao X., McGeehan J. et al. Insoluble aggregates and protease‐resistant conformers of prion protein in uninfected human brains. J. Biol. Chem, 2006; 281: 34848-34858.
https://doi.org/10.1074/jbc.M602238200
PMid:16987816

28. Yuan J., Kinter M., McGeehan J. et al. Concealment of epitope by reduction and alkylation in prion protein. Biochem. Biophys. Res. Commun, 2005;326: 652-659.
https://doi.org/10.1016/j.bbrc.2004.11.088
PMid:15596149

29. Zanata S.M., Lopes M.H., Mercadante A.F. et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J, 2002; 21: 3307-3316.
https://doi.org/10.1093/emboj/cdf325
PMid:12093732 PMCid:PMC125391

30. Zou W.Q., Langeveld J., Xiao X. et al. PrP conformational transitions alter species preference of a PrP‐specific antibody. J. Biol. Chem, 2010; 285: 13874-13884.
https://doi.org/10.1074/jbc.M109.088831
PMid:20194495 PMCid:PMC2859550

31. Zou W.Q., Puoti G., Xiao X. et al. Variably protease‐sensitive prionopathy: a new sporadic disease of the prion protein. Ann. Neurol, 2010; 68: 162-172.
https://doi.org/10.1002/ana.22094
PMid:20695009 PMCid:PMC3032610

32. Zou W.Q., Zhou X., Yuan J., Xiao X. Insoluble cellular prion protein and its association with prion and Alzheimer diseases. Prion J, 2011; 5: 172-178.
https://doi.org/10.4161/pri.5.3.16894
PMid:21847014 PMCid:PMC3226044

33. www.videotest.ru


Refbacks

  • There are currently no refbacks.


Copyright (c) 2011 Studia biologica

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.